FUZHOU WEIMEI PAPER CO.,LTD – Trademark Portfolio

Entity Type: 03

FUZHOU WEIMEI PAPER CO.,LTD holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 16 (Paper Goods) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CHILDHOOD SKY.

4#Workshop, No.15, Tieling West Road,

Ganzhe Street, Minhou County, Fuzhou Cit

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

FUZHOU WEIMEI PAPER CO.,LTD's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

16
Paper Goods (1 filing)

Paper and cardboard; printed matter; bookbinding material; photographs; stationery

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does FUZHOU WEIMEI PAPER CO.,LTD have?

FUZHOU WEIMEI PAPER CO.,LTD has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does FUZHOU WEIMEI PAPER CO.,LTD file in?

FUZHOU WEIMEI PAPER CO.,LTD files trademarks across 2 Nice Classification classes. The most active classes are Class 16 (Paper Goods), Class 5 (Pharmaceuticals). Class 16 covers paper and cardboard; printed matter; bookbinding material; photographs; stationery.

What are FUZHOU WEIMEI PAPER CO.,LTD's most well-known trademarks?

FUZHOU WEIMEI PAPER CO.,LTD's registered trademark portfolio includes well-known marks such as CHILDHOOD SKY. These are among 1 currently registered trademark in the portfolio.

What is FUZHOU WEIMEI PAPER CO.,LTD's trademark registration success rate?

FUZHOU WEIMEI PAPER CO.,LTD has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.